2011 Publications

Donate to our Cause

Videos

Browse the latest video presentations on topics such as cancer, heart disease, and oxidative stress from Randolph M. Howes, M.D., Ph.D.

View our Videos ›

Books

Download the latest books from The Howes Selective World Library of Oxygen Metabolism. Dr. Howes currently has 11 books in publication.

Browse the Online Store ›

Newsletter

“Crestor Questions”

Cholesterol lowering statin drugs, such as Crestor (rosuvastatin), were being taken by about 60 million Americans in 2007. Statins can allegedly save you from hardening of the arteries by raising so-called “good cholesterol (HDL)” and lowering supposedly “bad cholesterol (LDL).” In February 2010, the FDA broadened Crestor’s market by about 6 million more people, including healthy people, as the result of a study by the manufacturer of Crestor (AstraZeneca PLC). The FDA decided that Crestor is indicated for “the primary prevention of cardiovascular disease to reduce the risk of stroke, heart attack, and the risk of arterial revascularization procedures (including coronary artery bypass graft, or bypass grafting of a peripheral artery or carotid artery, or angioplasty or stent placement) in individuals who have no clinically evident heart disease but are at an increased risk of heart disease.” Unfortunately, Crestor has been associated with such debilitating side effects as Stevens-Johnson syndrome, type II diabetes, liver damage, stroke, heart attack, and muscle breakdown, which may lead to acute kidney damage.

Download the full article (a PDF).